Nanovista is developing novel, multi-modality imaging agents for oncology. Nanovista is enabling surgical oncologists with tools to visualize tumors in real-time during surgery with the goal of improving cancer surgery outcomes. The CF800 liposomal imaging agent accumulates specifically at the tumor boundary with healthy tissue and enables the precise visualization of multiple solid tumor types using existing operating room equipment with CT and near-infrared spectrum imaging capabilities.

Nanovista Inc. logo



Event details

Date: November 6 - 8, 2023

Event contact

Patrick Barry
Area Director
Europe: Automotive and Life Sciences


21 in total